The pathology of epithelial pre-malignancy of the gastrointestinal tract
- PMID: 11355911
- DOI: 10.1053/bega.2001.0169
The pathology of epithelial pre-malignancy of the gastrointestinal tract
Abstract
This chapter deals with pre-malignant epithelial lesions of the gastrointestinal tract that have the potential to become cancers. Pre-malignant lesions are divided into two types: those characterized by dysplastic mucosa and those without dysplasia. Examples of the two types are present in the oesophagus, stomach and intestine. In the oesophagus, dysplasia of the squamous epithelium is a precursor to squamous carcinoma. There are differences in interpretation between Western and Japanese pathologists in the diagnosis of oesophageal squamous lesions. Dysplasia in Barrett's oesophagus is regarded as a precursor of adenocarcinoma. The goal of endoscopic surveillance in Barrett's mucosa is the detection of high-grade dysplasia. There are several problems with our current knowledge of high-grade dysplasia and controversies regarding its management. There are differences in the interpretation of biopsies of gastric epithelial dysplasia between Japanese and Western pathologists. In the colon, pre-malignant lesions include dysplasia seen in inflammatory bowel disease and colonic adenomas. The most significant predictor of the risk of malignancy in patients with inflammatory bowel disease is the presence of dysplasia in colonic biopsies. Because of the similarity of neoplasia throughout the gastrointestinal tract, there have been attempts to unify its classification, terminology and diagnostic criteria internationally, the most recently proposed modified classification of gastrointestinal neoplasia being the Vienna classification. Dysplasia of the columnar mucosa has a similar appearance in Barrett's oesophagus, the stomach and the colon. Criteria for its histological diagnosis and grading are reviewed, with an emphasis on areas of diagnostic difficulty such as interobserver variation, and discrepancies between Western and Japanese pathologists. Implication of the presence of dysplasia that are specific to each organ site are discussed, highlighting weaknesses and controversies in current knowledge.
Copyright 2001 Harcourt Publishers Ltd.
Similar articles
-
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24. Gastrointest Endosc. 2009. PMID: 19555948
-
The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages.Virchows Arch. 2003 Feb;442(2):99-106. doi: 10.1007/s00428-002-0680-3. Epub 2002 Dec 13. Virchows Arch. 2003. PMID: 12596058 Review.
-
Dysplasia can be a pain in the gut.Pathology. 2002 Dec;34(6):518-28. Pathology. 2002. PMID: 12555989 Review.
-
International comparability of the pathological diagnosis for early cancer of the digestive tract: Munich meeting.J Gastroenterol. 2000;35 Suppl 12:102-10. J Gastroenterol. 2000. PMID: 10779228
-
Well-differentiated adenocarcinoma or dysplasia of the gastric epithelium: rationale for a new classification system.Verh Dtsch Ges Pathol. 1999;83:62-70. Verh Dtsch Ges Pathol. 1999. PMID: 10714196
Cited by
-
A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia.J Clin Pathol. 2004 Feb;57(2):177-82. doi: 10.1136/jcp.2003.11270. J Clin Pathol. 2004. PMID: 14747445 Free PMC article.
-
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).Endoscopy. 2012 Jan;44(1):74-94. doi: 10.1055/s-0031-1291491. Epub 2011 Dec 23. Endoscopy. 2012. PMID: 22198778 Free PMC article.
-
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).Virchows Arch. 2012 Jan;460(1):19-46. doi: 10.1007/s00428-011-1177-8. Epub 2011 Dec 22. Virchows Arch. 2012. PMID: 22190006
-
Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition.Front Oncol. 2021 Aug 26;11:709486. doi: 10.3389/fonc.2021.709486. eCollection 2021. Front Oncol. 2021. PMID: 34552870 Free PMC article.
-
Protein kinase Cbeta is an effective target for chemoprevention of colon cancer.Cancer Res. 2009 Feb 15;69(4):1643-50. doi: 10.1158/0008-5472.CAN-08-3187. Cancer Res. 2009. PMID: 19221092 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources